SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9380Our old friends, Stanford Research, out attacking SEPR and saying that a 30% redRobohogs-3/27/2006
9379And on the sleep front, some (if not most?) formularies still require prior authquidditch-3/27/2006
9378and if SEPR decides not to sell at this price, and there is a perceived small buIamarangerboy-3/27/2006
9377More colour on Xopenex and Medicare: Medicare/Home Health/Hospital is 40% of biRobohogs-3/27/2006
9376<How come none of these people get up and get on the treadmill?> LOL. dekenhott-3/27/2006
937517% was one quote I saw. I have also seen nums as high as 30%. Oh J code, oh JRobohogs-3/27/2006
9374Sweet. So it will price below their marginal cost to produce and sell :-) Anyrkrw-3/27/2006
9373Medicare pricing rollback in Northeast region. Pricing drop of about 90-95% fo Robohogs-3/27/2006
9372Considering that Lunesta dropped 2.4% last week (coming off of the beginning of Robohogs-3/27/2006
9371Here's the Ambien CR patent claim: <i>Claims: What is claimed is: 1Biomaven-3/24/2006
9370Incredible. I see the submission date was 1/19. CR was approved in early Sept. Hrkrw-3/24/2006
9369There is a paragraph IV challenge to Ambien CR on the FDA site. It would probablBiomaven-3/24/2006
9368Driving, Other Erratic Behaviors Reported After Taking Zolpidem Laurie Barclay, Icebrg-3/24/2006
9367Lyons once commented that due to familiarity, (especially) low prices and extenskeokalani'nui-3/24/2006
9366It would be interesting to study the inactive isomer of zopiclone and see what ituck-3/24/2006
9365Given zopiclone has been around in europe for many years with leading market sharkrw-3/24/2006
9364Sanofi, Sepracor Insomnia Pill Sales Slip on Sleepwalk Reports March 24 (BloombIcebrg-3/24/2006
9363I just noticed that MS has dropped coverage and Corey Davis has been replaced atRobohogs-3/22/2006
9362chron.com Spek Fears Low Sales on Ambien Publicity By THERESA AGOVINO AP BusinIamarangerboy-3/22/2006
9361SEPR down mostly due to Ambien class effect concerns. This goes for NBIX also. kenhott-3/22/2006
9360I do not keep hard data here at home. Sorry guys. But I can say mkt share was Robohogs-3/22/2006
9359Swim to the deep end, to the shady side of the pool.eomquidditch-3/22/2006
9358I have been taken to task too many times for posting bad data. NOT IT! Jon MaRobohogs-3/22/2006
9357I presume the continuous decline in the SEPR stock price is related to another lIamarangerboy-3/22/2006
9356Entry into a Material Definitive Agreement [Interesting to see that Southwell iIcebrg-3/21/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News